Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Therapeutic Experience Program (TEP) Study Assessing Adherence to On-Label PoNS® Therapy for Improvement of Gait in People With Multiple Sclerosis (MS) in a Real-World Clinical Setting

NCT05437276 is registered in ClinicalTrials.gov with Helius Medical Inc as lead sponsor.

NCT NCT05437276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05437276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Therapeutic Experience Program (TEP) Study Assessing Adherence to On-Label PoNS® Therapy for Improvement of Gait in People With Multiple Sclerosis (MS) in a Real-World Clinical Setting
Lead sponsor
Helius Medical Inc
Phase
Observational
Overall status
Completed
Start date
July 1, 2022
Completion date
December 31, 2024
Enrollment
43 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

gait impairment due to mild/moderate multiple sclerosis (ms)